Yu-Xiao Yang, MD, MSCE
Associate Professor of Medicine (Gastroenterology)
Attending Physician, Hospital of the University of Pennsylvania (HUP)
Attending Physician, Penn Presbyterian Medical Center (PPMC)
Attending Physician, Veterans Affairs Medical Center (VAMC)
Senior Scholar, Center for Epidemiology & Biostatistics, University of Pennsylvania
Co-Director, Gastroenterology and Hepatology Research Program, UPENN
Department: Medicine
Contact information
Center for Clinical Epidemiology and Biostatistics
423 Guardian Drive
733 Blockley Hall
Philadelphia, PA 19104
423 Guardian Drive
733 Blockley Hall
Philadelphia, PA 19104
Office: 215-573-5027
Email:
yangy@mail.med.upenn.edu
yangy@mail.med.upenn.edu
Publications
Links
Search PubMed for articles
University of Pennsylvania Perelman School of Medicine Center for Clinical Epidemiology and Biostatistics
Penn Medicine Esophageal and Swallowing Disorders Program
Search PubMed for articles
University of Pennsylvania Perelman School of Medicine Center for Clinical Epidemiology and Biostatistics
Penn Medicine Esophageal and Swallowing Disorders Program
Education:
BE (Electrical Engineering)
City College of New York, 1992.
MD
New York University School of Medicine, 1996.
MSCE
University of Pennsylvania, 2003.
Permanent linkBE (Electrical Engineering)
City College of New York, 1992.
MD
New York University School of Medicine, 1996.
MSCE
University of Pennsylvania, 2003.
Selected Publications
Wang L, Rahimi Larki N, Dobkin J, Salgado S, Ahmad N, Kaplan DE, Yang W, Yang YX.: A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With Acute Pancreatitis. Pancreas 53(3): e254-e259, 2024.Khan N, Sundararajan R, Patel M, Trivedi C, Yang YX.: Effectiveness of Tofacitinib in Patients With Ulcerative Colitis: A Nationwide Veterans Administration Cohort Study. Am J Gastroenterology 2024 Notes: In press.
Lam R, Hwang WT, Chennareddy S, Boursi B, Yang YX: Exogenous Insulin Therapy Is Associated with the Risk of Advanced Colorectal Adenoma in Patients with Diabetes Mellitus. Dig Dis Sci 2024 Notes: In Press.
Mezzacappa C, Larki NR, Skanderson M, Park LS, Brandt C, Hauser RG, Justice A, Yang YX, Wang L.: Development and Validation of Case-Finding Algorithms to Identify Pancreatic Cancer in the Veterans Health Administration. Dig Dis Sci 69(4): 1507-1513, 2024.
Kurlander JE, Laine L, Kim HM, Roberts CB, Saffar D, Myers A, Holleman R, Gao Y, Shank M, Nelson R, Forman J, Helfrich CD, Krein SL, Saini SD, Yang YX: Impact of large scale, multicomponent intervention to reduce proton pump inhibitor overuse in integrated healthcare system: difference-in-difference study. BMJ 385: e076484, 2024.
Wang L, Grimshaw AA, Mezzacappa C, Rahimi Larki N, Yang YX, Justice AC: Do polygenic risk scores add to clinical data in predicting pancreatic cancer? a scoping review. Cancer Epidemiol Biomarkers Prev August 2023 Notes: In press.
Hernandez-Con P, Shults J, Willis AW, Yang YX: Dopamine agonists and risk of lung cancer in patients with restless legs syndrome. Pharmacoepidemiol Drug Saf 32(7): 726-734, Jul 2023.
Brown TJ, Mamtani R, Gimotty PA, Karasic TB, Yang YX.: Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis. J Cancer Res Clin Oncol 149(6): 2345-2354, Jun 2023.
Thanawala SU, Kaplan DE, Falk GW, Beveridge CA, Schaubel D, Serper M, Yang YX.: Antibiotic Exposure is Associated With a Risk of Esophageal Adenocarcinoma. Clin Gastroenterol Hepatol S1542-3565(23): 00220-3, March 2023.
Tompkins WP, Hwang WT, Yang YX, Singh A, Ciunci C, D'Avella C, Aggarwal C, Cohen RB, Langer CJ, Mamtani R, Marmarelis ME.: Second-line treatment outcomes in patients with advanced NSCLC previously treated with first-line immunotherapy regimens. Clin Lung Cancer 24(6): 558-562, 2023.